Taken together, our results reveal a unique action mechanism of CSNK1G2 on PI3K/AKT/mTOR/S6K and ERK signaling pathways in breast cancer cells and provide insight into how the target selectively controls and contributes to cell survival in different human breast cancer cell types. The gene discussed is MTOR; the disease is breast carcinoma.